Cargando…
Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing
Chitosan is a natural biopolymer that is present in an abundant supply in sources such as crustacean shells, mushrooms, and insect exoskeletons. It can be used to make a variety of types of drug formulations and is generally safe to use in vivo; plus, it has inherent cholesterol-reducing properties....
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145436/ https://www.ncbi.nlm.nih.gov/pubmed/35631521 http://dx.doi.org/10.3390/pharmaceutics14050935 |
_version_ | 1784716315344240640 |
---|---|
author | Sriamornsak, Pornsak Dass, Crispin R. |
author_facet | Sriamornsak, Pornsak Dass, Crispin R. |
author_sort | Sriamornsak, Pornsak |
collection | PubMed |
description | Chitosan is a natural biopolymer that is present in an abundant supply in sources such as crustacean shells, mushrooms, and insect exoskeletons. It can be used to make a variety of types of drug formulations and is generally safe to use in vivo; plus, it has inherent cholesterol-reducing properties. While an abundance of papers has tested this biopolymer in nanoparticles in cancer and diabetes research, there is a lag of usage, and hence the paucity of information, in the area of cardiovascular research, specifically in atherosclerosis, the topic of this review. This review highlights some of the deficiencies in this niche area of research, examines the range of chitosan nanoparticles that have been researched to date, and proposes several ways forward to advance this field. Nanoparticles used for both diagnostic and therapeutic purposes are reviewed, with a discussion on how these nanoparticles could be better researched in future and what lays ahead as the field potentially moves towards clinical trials in future. |
format | Online Article Text |
id | pubmed-9145436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91454362022-05-29 Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing Sriamornsak, Pornsak Dass, Crispin R. Pharmaceutics Review Chitosan is a natural biopolymer that is present in an abundant supply in sources such as crustacean shells, mushrooms, and insect exoskeletons. It can be used to make a variety of types of drug formulations and is generally safe to use in vivo; plus, it has inherent cholesterol-reducing properties. While an abundance of papers has tested this biopolymer in nanoparticles in cancer and diabetes research, there is a lag of usage, and hence the paucity of information, in the area of cardiovascular research, specifically in atherosclerosis, the topic of this review. This review highlights some of the deficiencies in this niche area of research, examines the range of chitosan nanoparticles that have been researched to date, and proposes several ways forward to advance this field. Nanoparticles used for both diagnostic and therapeutic purposes are reviewed, with a discussion on how these nanoparticles could be better researched in future and what lays ahead as the field potentially moves towards clinical trials in future. MDPI 2022-04-25 /pmc/articles/PMC9145436/ /pubmed/35631521 http://dx.doi.org/10.3390/pharmaceutics14050935 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sriamornsak, Pornsak Dass, Crispin R. Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing |
title | Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing |
title_full | Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing |
title_fullStr | Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing |
title_full_unstemmed | Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing |
title_short | Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing |
title_sort | chitosan nanoparticles in atherosclerosis—development to preclinical testing |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145436/ https://www.ncbi.nlm.nih.gov/pubmed/35631521 http://dx.doi.org/10.3390/pharmaceutics14050935 |
work_keys_str_mv | AT sriamornsakpornsak chitosannanoparticlesinatherosclerosisdevelopmenttopreclinicaltesting AT dasscrispinr chitosannanoparticlesinatherosclerosisdevelopmenttopreclinicaltesting |